TECON BIOLOGY Co.LTD (SHE:002100)

China · Delayed Price · Currency is CNY

6.74

+0.22 (3.37%)

Jul 15, 2026, 10:55 AM CST

6.14% (1Y)

Market Cap	8.90B +4.2%
Revenue (ttm)	16.72B -4.9%
Net Income	-100.79M
EPS	-0.07
Shares Out	1.37B
PE Ratio	n/a
Forward PE	26.07
Dividend	0.08 (1.18%)
Ex-Dividend Date	Jun 10, 2026

Volume	12,571,997
Open	6.40
Previous Close	6.52
Day's Range	6.40 - 6.77
52-Week Range	5.64 - 8.46
Beta	0.57
Analysts	Strong Buy
Price Target	8.15 (+20.92%)
Earnings Date	Aug 27, 2026

About TECON BIOLOGY Co.LTD

TECON BIOLOGY Co.LTD, together with its subsidiaries, engages in the provision of animal health care, feed, pig breeding, agricultural product processing and trade, and financial services in China and internationally. The company offers pigs, poultry, dairy cows, ruminants, aquatic feed products, as well as premixes and additives. The Pharmaceutical division researches and develops livestock and poultry disease vaccine products; and cottonseed meal and oils, cotton hull, and short plush, as well as engages in pig genetics and breeding; commerci... [Read more]

Industry Packaged Foods

Sector Consumer Staples

Founded 1993

Employees 4,803

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 002100

Full Company Profile

Financial Performance

In 2025, TECON BIOLOGY Co.LTD's revenue was 16.98 billion, a decrease of -1.13% compared to the previous year's 17.18 billion. Earnings were 210.63 million, a decrease of -65.19%.

Financial Statements

Analyst Summary

According to 6 analysts, the average rating for 002100 stock is "Strong Buy." The 12-month stock price target is ¥8.15, which is an increase of 20.92% from the latest price.

Price Target

¥8.15

(20.92% upside)

Analyst Consensus: Strong Buy

Stock Forecasts